OOIR: Observatory of International Research

Papers

(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	79
Editorial Board	74
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	71
Recent advances in algorithms predicting hemodynamic instability undergoing surgery for phaeochromocytoma and paraganglioma	70
Editorial Board	54
Publisher's Note	54
Editorial Board	50
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency	42
Genetics of cryptorchidism and testicular regression	40
Newly detected diabetes during the COVID-19 pandemic: What have we learnt?	37
Genotype-phenotype correlations in Graves’ disease	35
Genetics of reproductive endocrinology	35
Editorial Board	34
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery	32
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	30
Editorial Board	29
Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors	29
Editorial Board	29
Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use	28
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	27
Second line treatment of acromegaly: Pasireotide or Pegvisomant?	27
Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases	25
Editorial Board	25
The pathophysiology of hypophosphatemia	24
Myeloma and marrow adiposity: Unanswered questions and future directions	24